- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03721536
Effects of Low-Flow Anesthesia on Hemodynamic Parameters and Oxygenation in Morbidly Obese Patients (Oxygenation)
Effects of Low-Flow Anesthesia on Hemodynamic Parameters and Oxygenation in Morbidly Obese Patients Undergoing Bariatric Surgery: A Prospective, Randomized Clinical Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Low-flow anesthesia has several potential benefits. It improves the flow dynamics of the inhaled air, increase mucociliary clearance, maintain body temperature, reduce fluid loss, result in savings of up to 75% and reduce greenhouse gas emissions and reduce treatment costs (10 - 13). However, it is necessary to examine whether the reduction of fresh gas flow affects the quality and safety of anesthesia management, especially during high-risk operations such as laparoscopic bariatric surgery.
Low-flow anesthesia has been used for years with positive results, but its effects on hemodynamic parameters and oxygenation are not clearly known in high-risk morbidly obese patients who are prone to pulmonary dysfunction related to the obesity. Therefore, this prospective randomized study aimed to compare the effects of low-flow (0.75 L/min) and normal-flow (1.5 L/min) anesthesia on hemodynamic parameters and oxygenation in morbidly obese patients undergoing laparoscopic bariatric surgery.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Türkiye-Türkçe
-
Malatya, Türkiye-Türkçe, Turkey, 44090
- Sedat Akbas
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Morbidly obese patients with American Society of Anesthesiology (ASA) scores of III-IV,
- Aged 18-65 years old,
- BMI>40
Exclusion Criteria:
- Pregnant
- Uncontrolled diabetes mellitus,
- Cardiovascular disease,
- Pulmonary disease,
- Cerebrovascular disease,
- Drug and alcohol addiction.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SCREENING
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: low-flow anesthesia
Patients in low-flow anesthesia receive a fresh gas flow of 4 L/min for the first 10 minutes and were then maintain with a fresh gas flow of 0.75 L/min.
Patients will be monitored for hemodynamic parameters during the perioperative period.
Arterial blood gase will be analyzed for the oxygenation.
|
vital signs on the monitor including heart rate, mean arterial pressure, peripheral oxygen saturation and End-tidal Carbon Dioxide
Other Names:
Arterial blood gas including partial oxygen pressure and partial carbon dioxide pressure is an important routine investigation to monitor the acid-base balance of patients, effectiveness of gas exchange, and the state of their voluntary respiratory control.
Other Names:
|
ACTIVE_COMPARATOR: normal-flow anesthesia
Patients in normal-flow anesthesia received a fresh gas flow of 4 L/min for the first 10 minutes and were then maintained with a fresh gas flow of 1.5 L/min.
Patients will be monitored for hemodynamic parameters during the perioperative period.
Arterial blood gase will be analyzed for the oxygenation.
|
vital signs on the monitor including heart rate, mean arterial pressure, peripheral oxygen saturation and End-tidal Carbon Dioxide
Other Names:
Arterial blood gas including partial oxygen pressure and partial carbon dioxide pressure is an important routine investigation to monitor the acid-base balance of patients, effectiveness of gas exchange, and the state of their voluntary respiratory control.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The level of partial oxygen pressure
Time Frame: From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)
|
The level of partial oxygen pressure is measured as mmHg in arterial blood gase analysis
|
From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart rate
Time Frame: From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)
|
Heart rate is measured as beats/minute on the anesthesia monitor
|
From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)
|
Mean arterial pressure
Time Frame: From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)
|
Mean arterial pressure is measured as mmHg on the anesthesia monitor
|
From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)
|
Peripheral oxygen saturation
Time Frame: From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)
|
Peripheral oxygen saturation is measured as percentage (%) on the anesthesia monitor
|
From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Sedat Akbas, Asst Prof, Inonu University Medical Faculty
Publications and helpful links
General Publications
- Nunn Geoffrey BA. Low-flow anaesthesia. Continuing Education in Anaesthesia Critical Care & Pain Volume 8, Issue 1, February 2008, Pages 1-4
Helpful Links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- sedatakbas4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Morbid Obesity
-
ClinTrio Ltd.UnknownMorbid Obesity Requiring Bariatric SurgeryBelgium, Germany, Portugal, Austria, Netherlands, Poland, Saudi Arabia
-
Centre Hospitalier Universitaire de NiceCompletedMorbid Obesity D009765France
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Hospices Civils de LyonCentre de Recherche en Nutrition Humaine Rhone-Alpe; Institut National de Recherche... and other collaboratorsRecruiting
-
Endolumik, IncWest Virginia UniversityNot yet recruitingMorbid ObesityUnited States
-
Rijnstate HospitalRecruiting
-
Laval UniversityCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie...Recruiting
-
University of WashingtonUnited States Department of DefenseWithdrawn
-
Helsinki University Central HospitalActive, not recruiting
-
IHU StrasbourgWithdrawnMorbid Obesity
Clinical Trials on hemodynamic parameters
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...Completed
-
Samsung Medical CenterShanghai Institute of Cardiovascular Diseases; Elucid Bioimaging Inc.Active, not recruitingAcute Coronary Syndrome | Ischemic Heart DiseaseKorea, Republic of, China
-
Mersin UniversityCompleted
-
Hospital Sirio-LibanesRecruiting
-
Hippocration General HospitalKAT General Hospital; Sismanoglio General Hospital; Thriasio General Hospital; Elpis... and other collaboratorsRecruitingMyocardial Infarction With Nonobstructive Coronary ArteriesGreece
-
Hacettepe UniversityCompletedSingle-ventricle | Exercise Capacity | Hemodynamic Instability | Arterial Stiffness | Muscle Oxygenation | Fontan ProcedureTurkey
-
Beijing Tongren HospitalCompletedGoal-directed Fluid TherapyChina
-
University Hospital Hradec KraloveRecruiting
-
Atlantic Health SystemTerminatedNeurological ManifestationsUnited States
-
University Health Network, TorontoCompletedIntraoperative Fluid ManagementCanada